See How NZ’s Publicly-Funded Lung Cancer Treatment Options Compare
This report provides a direct comparison of Non-Small Cell Lung Cancer Treatment Options:
New Zealand and Australia versus European Society for Medical Oncology (ESMO) Guidelines.
Sadly this report demonstrates how far behind Pharmac is with reimbursing standard of care treatments for NZ’s Biggest Cancer Killer and why lung cancer patients die prematurely in New Zealand.
LFNZ Lung Cancer Treatment Guidelines Comparisons – June 2019